BMK
GOODBenchmark Holdings to Delist from AIM and Euronext Growth Oslo
The major aquaculture biotechnology company is delisting from public markets as part of a plan to return proceeds from a business disposal to shareholders.
Benchmark Holdings
24.80GBX
1.64%
Market Cap
184.12M
Volume
15
0% of avg
P/E Ratio
0.12
EPS (TTM)
2.14
Beta
0.29
Day Range
0.00p - 0.00p
52 Week Range
0.00p24.80p44.47p
24.80p
Upcoming Events
BMK
BADBenchmark Holdings Reports Declining Revenues and Increased Losses in Half-Year Results
The aquaculture biotechnology firm reported a 22% revenue decline and increased operating losses in its half-year results, facing headwinds in key markets and uncertainty from new US tariffs.
BMK
NEUTRALBenchmark Holdings Announces Change of Time for Retail Investor Webcast
The aquaculture biotechnology company has announced a change of time for its upcoming retail investor webcast.
BMK
NEUTRALBenchmark Holdings Announces Holding Change
The retailer has announced a change in its major shareholding structure.
BMK
NEUTRALBenchmark Holdings Announces Interim Results Webcast
The aquaculture biotechnology company will host webcasts to present its interim results for the six-month period ended 31 March 2025.
BMK
GOODBenchmark Holdings to Delist from AIM and Euronext Growth Oslo, Return Majority of Genetics Disposal Proceeds to Shareholders
The major aquaculture biotechnology company plans to delist from public markets and return the majority of proceeds from a recent business disposal to shareholders.
BMK
NEUTRALBenchmark Holdings Provides Update on Strategy and Return of Capital
The aquaculture biotechnology company announces an update on its strategic direction and plans to return capital to shareholders.
BMK
NEUTRALBenchmark Holdings Completes Bond Redemption
The retailer has completed the redemption of its outstanding senior secured bonds.
BMK
NEUTRALBenchmark Holdings Exercises Call Option to Redeem Bonds
The company has notified bondholders that it will exercise a call option to redeem all outstanding bonds under its senior unsecured bond issue.
BMK
GOODBenchmark Completes Disposal of Genetics Business for £260 Million
The aquaculture biotechnology company has completed the sale of its genetics business for £260 million, boosting its cash position and allowing it to focus on core operations.